Metformin hydrochloride crystallization drying device
By designing a crystal drying device for metformin hydrochloride, the combination of circulation pump, semiconductor refrigeration sheet and electric heating rod is used to solve the temperature control and agglomeration problems in the existing technology, the crystallization effect of metformin hydrochloride is improved, and the recycling and reuse of resources is realized .
Patent Information
- Application Number
- CN202420667424.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-02
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2034-04-02
AI Technical Summary
The existing metformin hydrochloride crystallization and drying devices are arranged separately, and the temperature control of below -10°C during the crystallization process is required. It is easy to agglomerate during the drying process, affecting the crystal form, and the increase in the temperature of the circulation liquid affects the crystallization effect.
A crystal drying device of metformin hydrochloride is designed, including a crystal drying box and a circulation mechanism. The circulation mechanism includes a cooling box, a semiconductor refrigeration sheet, an electric heating rod and a vibrator. The cooling liquid circulation is controlled through the circulation pump and valve to achieve the flushing of metformin hydrochloride. and refrigeration, electric heating rods are dried and crystallization efficiency is improved by a vibrator.
The crystallization effect of metformin hydrochloride is improved, blocked, and the recycling of crystallization circulation liquid is achieved, resources are saved, and the refrigeration effect is enhanced.
Smart Images

Figure CN222056409U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the field of raw material medicine preparation devices, in particular to a metformin hydrochloride crystallization drying device. Background Art
[0002] In recent years, with the rapid development of my country's national economy and the continuous improvement of people's living standards, the incidence of some diseases that endanger people's health has also changed accordingly. Among them, the increase in the incidence of diabetes and the younger age of patients are particularly prominent. Therefore, the clinical use of diabetes medication is very important, and metformin can be said to be the most popular oral glucose-lowering Western medicine.
[0003] The commonly used metformin hydrochloride crystallization and drying devices are arranged separately, and the temperature needs to be controlled below -10°C during the crystallization process to precipitate the metformin hydrochloride in the solution as much as possible. It is easy to agglomerate during the drying process, and the agglomerates need to be treated after drying, which affects its crystal form.
[0004] The authorized patent with application number: 201922135766.1 includes a circulating pump, a box, a control device and a cooler. A feed port is provided at the upper end of the box, a scale control valve is provided between the feed port and the box, at least three layers of drying devices are provided inside the box, the drying device includes a drying plate, and a heating device and a temperature sensor provided at the bottom of the drying plate, the temperature sensor is connected to the control device through a temperature control device outside the box, and the temperature control device also controls the connection to the heating device. A filter membrane is also closely provided on the drying plate; a solution collecting device is provided at the bottom inner side of the box, the circulating pump inlet is connected to the outlet of the solution collecting device, and the circulating pump outlet is connected to the inlet of the box.
[0005] The above-mentioned comparative documents include the following issues:
[0006] After long-term circulation, the temperature of the circulating fluid will gradually increase. When it reaches above -10°C, the crystallization effect of metformin hydrochloride will deteriorate.
[0007] Therefore, we made improvements to this and proposed a metformin hydrochloride crystallization and drying device. Utility Model Content
[0008] In order to solve the above technical problems, the utility model provides the following technical solutions:
[0009] The utility model discloses a metformin hydrochloride crystallization drying device, comprising a crystallization drying box, on which a circulation mechanism is fixedly installed;
[0010] The circulation mechanism includes a cooling box, which is fixedly installed at the lower end of the crystallization drying box, and the upper end of the cooling box is connected to the lower end of the crystallization drying box, and the left end of the bottom of the cooling box is fixedly connected with a second connecting pipe, the other end of the second connecting pipe passes through the upper end of the crystallization drying box and extends to the inside of the crystallization drying box, and is fixedly connected with an inlet and outlet head, and a plurality of openings are arranged on the inlet and outlet head;
[0011] A filter plate is installed inside the crystallization drying box, and a plurality of electric heating rods are arranged inside the filter plate;
[0012] A circulation pump is fixedly installed on the second connecting pipe and located on the left end surface of the cooling box, and a first switch valve is installed on the second connecting pipe;
[0013] The cooling box is provided with a crystallization circulating liquid, a semiconductor refrigeration plate is fixedly installed at the front end of the cooling box, and a rear cooling end of the semiconductor refrigeration plate passes through the front end of the cooling box and extends into the interior of the cooling box and contacts with the crystallization circulating liquid.
[0014] As an optimal technical solution of the utility model, a vibrator is fixedly installed in the middle of the rear end surface of the crystallization drying box. The front end of the vibrator output end passes through the crystallization drying box and extends into the interior of the crystallization drying box, and is fixedly connected to the middle of the rear end of the filter plate.
[0015] As a preferred technical solution of the utility model, a take-in and put-out opening is provided at the front end of the crystallization drying box, and a take-in and put-out door panel is installed at the take-in and put-out opening.
[0016] As a preferred technical solution of the utility model, the front end of the second connecting pipe is fixedly connected with the first connecting pipe at a position above the first switch valve, the lower end of the first connecting pipe is fixedly connected with the liquid inlet end of the upper end of the cooler, the liquid outlet end of the lower end of the cooler is fixedly connected with the third connecting pipe, and the other end of the third connecting pipe is fixedly connected with the left end of the bottom of the cooling box.
[0017] As a preferred technical solution of the utility model, a second switch valve is fixedly installed on the first connecting pipe.
[0018] As a preferred technical solution of the utility model, a rubber shock-absorbing pad is fixedly provided at the lower end of the cooling box.
[0019] The beneficial effects of the utility model are:
[0020] 1. This metformin hydrochloride crystallization and drying device can start the circulation pump, open the first switch valve, and close the second switch, so that the crystallization circulating liquid in the cooling box can be sucked into the inlet and outlet head through the second connecting pipe. The sprayed crystallization circulating liquid can flush the metformin hydrochloride to make it crystallize. The flushed crystallization circulating liquid falls into the cooling box. By starting the semiconductor refrigeration sheet, the crystallization circulating liquid can be continuously cooled, thereby improving the refrigeration effect of the crystallization circulating liquid on the metformin hydrochloride.
[0021] 2. This kind of metformin hydrochloride crystallization drying device, then start the electric heating rod, the electric heating rod can dry the metformin hydrochloride, open the second switch valve, and close the first switch valve, the drying can make the crystallization circulating liquid remaining on the metformin hydrochloride gasified, the crystallization circulating liquid gas enters the first connecting pipe through the second connecting pipe, and enters the cooler, the crystallization circulating liquid generated by cooling flows into the cooling box and can continue to be used. Through the above design, it is convenient to recycle the residual crystallization circulating liquid on the metformin hydrochloride, and achieve the effect of saving resources.
[0022] The utility model can rinse metformin hydrochloride through crystallization circulating liquid to make it crystallize, and can continuously refrigerate the crystallization circulating liquid, thereby improving the refrigeration effect of the crystallization circulating liquid on metformin hydrochloride, and can facilitate the recovery and reuse of the crystallization circulating liquid remaining on the metformin hydrochloride, thereby achieving the effect of saving resources. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] The accompanying drawings are used to provide a further understanding of the present invention and constitute a part of the specification. Together with the embodiments of the present invention, they are used to explain the present invention and do not constitute a limitation of the present invention. In the accompanying drawings:
[0024] Figure 1 It is a structural schematic diagram of a metformin hydrochloride crystallization and drying device of the utility model;
[0025] Figure 2 It is a structural schematic diagram of a circulation mechanism in a metformin hydrochloride crystallization and drying device of the utility model;
[0026] Figure 3 The utility model is a cross-sectional view of a crystallization drying box in a metformin hydrochloride crystallization drying device.
[0027] In the figure: 1. Crystallization drying oven; 2. Circulation mechanism; 3. Filter plate; 4. Vibration machine;
[0028] 201, cooling box; 202, semiconductor refrigeration plate; 203, first connecting pipe; 204, cooler; 205, first switch valve; 206, second connecting pipe; 207, second switch valve; 208, inlet and outlet head; 209, circulation pump; 210, third connecting pipe. DETAILED DESCRIPTION
[0029] The preferred embodiments of the present invention are described below in conjunction with the accompanying drawings. It should be understood that the preferred embodiments described herein are only used to illustrate and explain the present invention, and are not used to limit the present invention.
[0030] Example: Figure 1-3 As shown, the utility model is a metformin hydrochloride crystallization drying device, comprising a crystallization drying box 1, on which a circulation mechanism 2 is fixedly installed;
[0031] The circulation mechanism 2 includes a cooling box 201, which is fixedly mounted on the lower end of the crystallization drying box 1, and the upper end of the cooling box 201 is connected to the lower end of the crystallization drying box 1. The left end of the bottom of the cooling box 201 is fixedly connected with a second connecting pipe 206, and the other end of the second connecting pipe 206 passes through the upper end of the crystallization drying box 1 and extends to the inside of the crystallization drying box 1, and is fixedly connected with an inlet and outlet head 208, and a plurality of openings are provided on the inlet and outlet head 208;
[0032] A filter plate 3 is installed inside the crystallization drying box 1, and a plurality of electric heating rods are arranged inside the filter plate 3;
[0033] A circulation pump 209 is fixedly installed on the second connecting pipe 206 and located on the left end surface of the cooling box 201, and a first switch valve 205 is installed on the second connecting pipe 206;
[0034] A crystallization circulating liquid is arranged in the cooling box 201, a semiconductor refrigeration plate 202 is fixedly installed at the front end of the cooling box 201, and a rear cooling end of the semiconductor refrigeration plate 202 passes through the front end of the cooling box 201, extends to the inside of the cooling box 201, and contacts with the crystallization circulating liquid.
[0035] In this embodiment, Figure 3 As shown, a vibrator 4 is fixedly installed at the middle position of the rear end surface of the crystallization drying box 1. The front end of the output end of the vibrator 4 penetrates the crystallization drying box 1 and extends to the inside of the crystallization drying box 1, and is fixedly connected to the middle position of the rear end of the filter plate 3.
[0036] By starting the vibrator 4, the vibrator 4 drives the filter plate 3 to vibrate, and the vibrating filter plate 3 can continuously vibrate the metformin hydrochloride raw material to loosen it, thereby improving the drying efficiency of the metformin hydrochloride crystals.
[0037] like Figure 1As shown, a take-in and put-out opening is provided at the front end of the crystallization drying box 1, and a take-in and put-out door panel is installed at the take-in and put-out opening.
[0038] The access door is opened, and the metformin hydrochloride raw material can be taken out of and put into the filter plate 3 through the access opening.
[0039] like Figure 2 As shown, the front end of the second connecting tube 206 is fixedly connected to the first connecting tube 203 at a position above the first switch valve 205, the lower end of the first connecting tube 203 is fixedly connected to the liquid inlet end of the upper end of the cooler 204, the lower end of the liquid outlet end of the cooler 204 is fixedly connected to the third connecting tube 210, the other end of the third connecting tube 210 is fixedly connected to the left end of the bottom of the cooling box 201, and the second switch valve 207 is fixedly installed on the first connecting tube 203.
[0040] Open the second switch valve 207 and close the first switch valve 205. Drying can vaporize the crystallization circulating liquid remaining on the metformin hydrochloride. The crystallization circulating liquid gas enters the first connecting pipe 203 through the second connecting pipe 206 and enters the cooler 204. The crystallization circulating liquid generated by cooling flows into the cooling box 201 and can continue to be used.
[0041] like Figure 1 As shown, a rubber shock-absorbing pad is fixedly arranged at the lower end of the cooling box 201. The rubber shock-absorbing pad can improve the shock-absorbing effect of the utility model.
[0042] When working,
[0043] Open the access door, put the metformin hydrochloride onto the filter plate 3 through the access port, and close the access door;
[0044] By starting the circulation pump 209, opening the first switch valve 205, and closing the second switch, the crystallization circulating liquid in the cooling box 201 can be sucked into the inlet and outlet head 208 through the second connecting pipe 206, and the inlet and outlet head 208 sprays the crystallization circulating liquid through multiple openings. The sprayed crystallization circulating liquid can rinse the metformin hydrochloride to make it crystallize. The rinsed crystallization circulating liquid falls into the cooling box 201. By starting the semiconductor refrigeration sheet 202, the crystallization circulating liquid can be continuously cooled, thereby improving the cooling effect of the crystallization circulating liquid on the metformin hydrochloride;
[0045] Then, the electric heating rod is started, and the operation of the electric heating rod can dry the metformin hydrochloride. The second switch valve 207 is opened, and the first switch valve 205 is closed. Drying can gasify the crystallization circulating liquid remaining on the metformin hydrochloride. The crystallization circulating liquid gas enters the inlet and outlet head 208 through the opening, and enters the second connecting pipe 206 along the inlet and outlet head 208, enters the first connecting pipe 203, and enters the cooler 204. The crystallization circulating liquid generated by cooling flows into the cooling box 201 and can continue to be used.
[0046] Finally, the access door is opened to take out the metformin hydrochloride on the filter plate 3 .
[0047] Finally, it should be noted that the above description is only a preferred embodiment of the utility model and is not intended to limit the utility model. Although the utility model is described in detail with reference to the above embodiments, those skilled in the art can still modify the technical solutions recorded in the above embodiments or replace some of the technical features therein by equivalents. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the utility model shall be included in the protection scope of the utility model.
Claims
1. A metformin hydrochloride crystallization and drying device, characterized in that: It comprises a crystallization drying box (1), on which a circulation mechanism (2) is fixedly installed; The circulation mechanism (2) comprises a cooling box (201), wherein the cooling box (201) is fixedly mounted on the lower end of the crystallization drying box (1), and the upper end of the cooling box (201) is connected to the lower end of the crystallization drying box (1), and the left end of the bottom of the cooling box (201) is fixedly connected to a second connecting pipe (206), the other end of the second connecting pipe (206) passes through the upper end of the crystallization drying box (1) and extends to the interior of the crystallization drying box (1), and is fixedly connected to an inlet and outlet head (208), and a plurality of openings are provided on the inlet and outlet head (208); A filter plate (3) is installed inside the crystallization drying box (1), and a plurality of electric heating rods are arranged inside the filter plate (3); A circulation pump (209) is fixedly installed on the second connecting pipe (206) and located on the left end surface of the cooling box (201), and a first switch valve (205) is installed on the second connecting pipe (206); The cooling box (201) is provided with a crystallization circulating liquid, a semiconductor refrigeration plate (202) is fixedly installed at the front end of the cooling box (201), and a rear refrigeration end of the semiconductor refrigeration plate (202) passes through the front end of the cooling box (201) and extends into the interior of the cooling box (201) and contacts with the crystallization circulating liquid.
2. A metformin hydrochloride crystallization and drying device according to claim 1, characterized in that: A vibrator (4) is fixedly mounted at the middle of the rear end surface of the crystallization drying box (1); the front end of the output end of the vibrator (4) penetrates the crystallization drying box (1) and extends into the interior of the crystallization drying box (1), and is fixedly connected to the middle of the rear end of the filter plate (3).
3. A metformin hydrochloride crystallization and drying device according to claim 2, characterized in that: The front end of the crystallization drying box (1) is provided with a take-in / take-out opening, and a take-in / take-out door panel is installed at the take-in / take-out opening.
4. A metformin hydrochloride crystallization and drying device according to claim 3, characterized in that: The front end of the second connecting tube (206) and a position above the first switch valve (205) are fixedly connected to the first connecting tube (203); the lower end of the first connecting tube (203) is fixedly connected to the liquid inlet end of the upper end of the cooler (204); the lower end of the liquid outlet end of the cooler (204) is fixedly connected to the third connecting tube (210); the other end of the third connecting tube (210) is fixedly connected to the left end of the bottom of the cooling box (201).
5. A metformin hydrochloride crystallization and drying device according to claim 4, characterized in that: A second switch valve (207) is fixedly mounted on the first connecting pipe (203).
6. A metformin hydrochloride crystallization and drying device according to claim 5, characterized in that: A rubber shock-absorbing pad is fixedly arranged at the lower end of the cooling box (201).
